KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viatris (VTRS) Cash & Equivalents: 2018-2025

Historic Cash & Equivalents for Viatris (VTRS) over the last 5 years, with Sep 2025 value amounting to $975.3 million.

  • Viatris' Cash & Equivalents fell 48.09% to $975.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $975.3 million, marking a year-over-year decrease of 48.09%. This contributed to the annual value of $734.8 million for FY2024, which is 26.05% down from last year.
  • Per Viatris' latest filing, its Cash & Equivalents stood at $975.3 million for Q3 2025, which was up 72.19% from $566.4 million recorded in Q2 2025.
  • Viatris' 5-year Cash & Equivalents high stood at $1.9 billion for Q3 2024, and its period low was $506.6 million during Q1 2023.
  • Moreover, its 3-year median value for Cash & Equivalents was $917.2 million (2024), whereas its average is $934.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 102.51% in 2023, then tumbled by 48.09% in 2025.
  • Viatris' Cash & Equivalents (Quarterly) stood at $706.2 million in 2021, then spiked by 78.41% to $1.3 billion in 2022, then decreased by 21.14% to $993.6 million in 2023, then declined by 26.05% to $734.8 million in 2024, then slumped by 48.09% to $975.3 million in 2025.
  • Its Cash & Equivalents stands at $975.3 million for Q3 2025, versus $566.4 million for Q2 2025 and $755.0 million for Q1 2025.